Current Situation of Blood Transfusion: An Article of Opinion
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2017, Vol 1, Issue 1
Abstract
The blood transfusion is an essential part of modern medical care. Used properly can save lives. Throughout the world, the centers that make blood products strive to provide safe of them, since the process of the transfusion could be without risks. At this point is essential the rational use of the same, imposing the need to balance the benefits and potential side effects that could produce like allergic and hemolytic reactions, metabolic processes, effects on cellular immunomodulation, lung damage or transmission of infectious diseases (HIV, HBV and HCV, among others). According to the data of the American Society of Blood Banks (AABB), approximately 85 million units of red blood cells administered annually, making the transfusion such as 8th key of all interventions capable of saving lives in centers that perform surgery (35% of the total needs of blood products), emergency obstetric care (25% of the transfusion requirements), organs and tissues transplants (20% of the requirements of blood transfusion), traffic accidents (10% of the total blood products administered, oncological patients (6% of the transfusion requirements) and chronic diseases (4% of the needs of blood products) (Figure 1). The donation, source of different types of blood products, must be voluntary, altruistic and non-remunerated, running as the safest in terms of minimizing the possibility of transmission of infectious diseases, thus ensuring the quality, availability and accessibility of blood transfusion. This process facing the individual and where a series of internal and external elements that interact to influence risk factors for presenting an adverse reaction to donation, understanding this as any unexpected event that appears at the time of the donation and that puts at risk the integrity, stability and/or the health of the donor, by causing disability and/or disease. On the other hand the improvement and greater accessibility of laboratory tests and their indiscriminate use, constitute the basis of the decision to transfuse, resulting in an inappropriate use of the blood products. In this context, it is essential to the establishment of clinical protocols, supported in the relevant complementary analytical tests mandatory for the staff involved in the transfusion act at a given time in order to optimize the use of this valuable resource. We always have to transfuse the patient, not to the analytical”.
Authors and Affiliations
Alcaraz Rubio Jesús
Keywords
Related Articles
- EP ID EP567558
- DOI 10.26717/BJSTR.2017.01.000149
- Views 198
- Downloads 0
Hyaline Cartilage Regeneration on Osteochondral defects by Intraarticular Injection of Human Peripheral Blood CD34+ Cells, Hyaluronic Acid and Growth Factor in a Rat Model
The knee joint cartilage often suffers from defect and it causes serious health problem. CD34+ stem cells have been studied to heal bone fracture however the cells has never been studied to repair cartilage. This study a...
Rare Occurrence of Two Cases of Congenital Syngnathia at Osmania General Hospital, Hyderabad, India: A Case Report
Syngnathia is a rare anomaly that involves fusion between the maxilla and the mandible. The fusion may be due to adhesions of the soft tissue between the bony fusion between maxilla and mandible. The latter is a very rar...
Switching from Allopurinol to Febuxostat: A Comparison of The Rate of Renal Functional Decline in Patients With Moderate and Severe Chronic Kidney Disease
Allopurinol has been widely used as a urate-lowering agent in the treatment of hyperuricemia. However, patients with renal impairment require dose reduction according to their renal function. On the other hand, strict do...
Mas Spec Pen”, The New Future For Cancer Diagnosis: Mini Review
Our intention is to give an outline and aware about recent innovation called Mas-Spec Pen developed at the University of Texas. This innovation could revolutionize the cancer diagnosis in upcoming days. Jialing Zihanget...
Tessier No. 3 Facial Cleft: Surgical and Orthopaedic Treatment A Literature Review
Tessier No. 3 is one of three types of oblique facial clefts according to Tessier's classification. This serious and rare congenital anomaly requires many specialized reconstructive operations and long-term postoperative...